Balyasny Asset Management
PRCT icon

Balyasny Asset Management’s Procept Biorobotics PRCT Stock Holding History

Balyasny Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
+73,942
New +$2.08M ﹤0.01% 1815
2024
Q1 		– Sell
-37,797
Closed -$1.58M – 3011
2023
Q4 		$1.58M Buy
37,797
+11,060
+41% +$377K ﹤0.01% 1521
2023
Q3 		$877K Buy
+26,737
New +$912K ﹤0.01% 1597
2021
Q4 		– Sell
-29,355
Closed -$1.12M – 2524
2021
Q3 		$1.12M Buy
+29,355
New +$1.13M ﹤0.01% 1301

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balyasny Asset Management's PRCT Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 73,942 shares worth $1.85M. The stake represents ﹤0.01% of the portfolio and ranks #1815 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in PRCT as recently as Q4 2023.

Balyasny Asset Management first reported a position in PRCT in Q3 2021 and has held it in 4 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Balyasny Asset Management held 73,942 shares of Procept Biorobotics worth $1.85M as of Q1 2026.
  • Procept Biorobotics was a new Balyasny Asset Management position in Q1 2026.
  • Procept Biorobotics made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1815 holding.
  • Balyasny Asset Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 4 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.